Results 291 to 300 of about 66,268 (303)

Screening for potential novel probiotic Lactobacillus strains based on high dipeptidyl peptidase IV and α-glucosidase inhibitory activity

Journal of Functional Foods, 2016
Zhu Zeng, Jun-Yi Luo, Fanglei Zuo
exaly  

Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes

Expert Opinion on Drug Safety, 2015
André J Scheen
exaly  

Dipeptidyl peptidase-4 inhibitors/metformin

Reactions Weekly, 2018
openaire   +1 more source

Dipeptidyl peptidase IV (DPP IV) inhibitors: a newly emerging drug class for the treatment of type 2 diabetes

Diabetes and Vascular Disease Research, 2006
Brian D Green, Peter Flatt
exaly  

A Role for Dipeptidyl Peptidase IV in Suppressing the Malignant Phenotype of Melanocytic Cells

Journal of Experimental Medicine, 1999
exaly  

Dipeptidyl peptidase-4 inhibitors: sensitivity markers

Biotechnology. Theory and practice, 2017
A.N. Iskakova, A.M. Aitkulova, N.S. Sikhayeva, A.A. Romanova, L. Maratkyzy, Zh. A. Akanov, E.V. Zholdybayeva   +6 more
openaire   +1 more source

Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors: From Risk Factors to Clinical Outcomes

Postgraduate Medicine, 2013
André J Scheen
exaly  

Alogliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits

Journal of the American Heart Association, 2017
Ning Jiang, Xue Liang, Gary Tse
exaly  

Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety

Expert Opinion on Pharmacotherapy, 2013
Carolyn F Deacon, Jens J Holst Dmsci
exaly  

Dipeptidyl nitriles as human dipeptidyl peptidase I inhibitors

Bioorganic and Medicinal Chemistry Letters, 2006
exaly